Discovery of 2,4-diarylaminopyrimidine derivatives bearing sulfonamide moiety as novel FAK inhibitors

Ridong Li(Peking University), Yuxin Yin(Peking University), Lidong Gong(Peking University), Zhiqiang Lin(Peking University), Huajie Song(Peking University), Runtao Li(Zhengzhou University), Qiang Zhang(China Pharmaceutical University), Jiawei Sun(Peking University), Junjie Huang(Zhejiang Medicine (China)), Xianling Ning(Peking University), Jianan He(Zhejiang Medicine (China)), Zichao Liang(Peking University)
Bioorganic Chemistry
January 17, 2024
10.1016/j.bioorg.2024.107134
Cited by 3

Related Papers

Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity
|Journal of Controlled Release|2015|255
SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation
|Cancer Research|2017|237
Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis
|Nature Cell Biology|2015|230
A Porous Au@Rh Bimetallic Core–Shell Nanostructure as an H<sub>2</sub>O<sub>2</sub>‐Driven Oxygenerator to Alleviate Tumor Hypoxia for Simultaneous Bimodal Imaging and Enhanced Photodynamic Therapy
|Advanced Materials|2020|216
Novel thermo-sensitive hydrogel system with paclitaxel nanocrystals: High drug-loading, sustained drug release and extended local retention guaranteeing better efficacy and lower toxicity
|Journal of Controlled Release|2013|211